13D Filing: OrbiMed Advisors and Roka Bioscience Inc. (ROKA)

Page 10 of 11

Page 10 of 11 – SEC Filing

Schedule II
The business and operations of OrbiMed Capital GP III LLC are managed by the executive officers and directors of its managing member, OrbiMed Advisors LLC, set forth on Schedule I attached hereto.

Follow Roka Bioscience Inc. (NASDAQ:ROKA)

Page 10 of 11